Orthogon Therapeutics

About:

Orthogon Therapeutics is a drug development company.

Website: https://www.orthogontherapeutics.com

Top Investors: Holbrook Angels of Boston, Over-the-Rhine Ventures

Description:

Orthogon Therapeutics is a pre-clinical stage, drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets.

Total Funding Amount:

$12.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Canton, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)orthogontherapeutics.com

Founders:

Ali Munawar

Number of Employees:

1-10

Last Funding Date:

2021-11-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai